Home > Nanotechnology Columns > Bergeson & Campbell, P.C. > IARC Advisory Group Recommends Multi-Walled Carbon Nanotubes as High Priority
 |
Lynn L. Bergeson Managing Director Bergeson & Campbell, P.C. |
Abstract:
An International Agency for Research on Cancer (IARC) Advisory Group met on April 7-9, 2014, to recommend priorities for IARC Monographs during 2015-2019.
May 12th, 2014
IARC Advisory Group Recommends Multi-Walled Carbon Nanotubes as High Priority
An International Agency for Research on Cancer (IARC) Advisory Group met on April 7-9, 2014, to recommend priorities for IARC Monographs during 2015-2019. See http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045%2814%2970168-8/fulltext The Advisory Group assessed the responses to a call for nominations and recommended a range of agents and exposures as high or medium priorities for assessment. According to the recommendations published in Lancet Oncology, multi-walled carbon nanotubes are a high priority for assessment -- "cancer bioassay data are available from intraperitoneal injection studies, inhalation studies are ongoing; mechanistic similarities with asbestos have been noted." IARC's preliminary list of agents to be reviewed at its September 30-October 7, 2014, meeting includes "carbon nanotubes."
Bookmark:
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||